Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Step by step instructions to Integrate Lab Precious stones into Special Adornments Pieces - 2Israel approves 19 new West Bank settlements in major annexation push
- 3Senegal limits foreign trips for officials as the fallout from Iran war deepens
- 4In the background: Visiting Notable Film Areas All over the Planet
- 5Vote in favor of Your #1 4\u00d74 SUVs
- The risk of falling space junk hitting airplanes is on the rise, experts warn
- Tuesday, April 7. Russia’s War On Ukraine: News And Information From Ukraine
- Florence's Uffizi Gallery moves treasures to safety after cyberattack
- Addressing sleep apnea early might decrease chances of developing Parkinson's disease
- RFK Jr. says fewer flu shots for kids may be 'better.' What experts say.
- Involved Vehicles for Seniors: Track down the Best Picks for Solace and Unwavering quality
- The 20 Most sultry Style of the Time
- EU Commission slams Israel's death penalty law for Palestinians
- 20-year-old who threatened German train attack remanded in custody
